Found: 81
Select item for more details and to access through your institution.
The fox guarding the clinical trial: internal vs. external validity in randomized studies.
- Published in:
- 1999
- By:
- Publication type:
- Letter
Attitudes of Canadian Oncology Practitioners Toward Psychosocial Interventions in Clinical and Research Settings in Women With Breast Cancer.
- Published in:
- Psycho-Oncology, 1997, v. 6, n. 3, p. 178, doi. 10.1002/(SICI)1099-1611(199709)6:3<178::AID-PON271>3.0.CO;2-O
- By:
- Publication type:
- Article
Overdiagnosing Overdiagnosis.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 134, doi. 10.1634/theoncologist.2012-0342
- By:
- Publication type:
- Article
A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium.
- Published in:
- Oncologist, 2010, v. 15, n. 8, p. 810, doi. 10.1634/theoncologist.2010-0081
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 5, p. 457, doi. 10.1634/theoncologist.2009-0275
- By:
- Publication type:
- Article
Review of the Clinical Studies Using the 21-Gene Assay.
- Published in:
- Oncologist, 2010, v. 15, n. 5, p. 447, doi. 10.1634/theoncologist.2009-0277
- By:
- Publication type:
- Article
Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Bone-Targeted Therapy in Early Breast Cancer.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 11, p. 562
- By:
- Publication type:
- Article
The Role of Bisphosphonates in Early- and Advanced-Stage Breast Cancer: Have We Finally Optimized Care?
- Published in:
- Oncology (08909091), 2015, v. 29, n. 1, p. 23
- By:
- Publication type:
- Article
First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 218, doi. 10.1159/000336892
- By:
- Publication type:
- Article
Prospective Evaluation of the Impact of the 21‐Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node‐Positive Breast Cancer in Ontario, Canada.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 768, doi. 10.1634/theoncologist.2017-0346
- By:
- Publication type:
- Article
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 12, doi. 10.1634/theoncologist.2016-0185
- By:
- Publication type:
- Article
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression.
- Published in:
- Oncologist, 2015, v. 20, n. 5, p. 474, doi. 10.1634/theoncologist.2014-0372
- By:
- Publication type:
- Article
Systemic Adjuvant Therapy for Node--Negative Breast Cancer: Proven or Premature?
- Published in:
- 1989
- By:
- Publication type:
- Editorial
Screening for endometrial cancer: is it effective?
- Published in:
- 1989
- By:
- Publication type:
- journal article
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 10, p. 1908, doi. 10.1002/cncr.28010
- By:
- Publication type:
- Article
Biological Significance of Occult Micrometastases in Histologically Negative Axillary Lymph Nodes in Breast Cancer Patients Using the Recent American Joint Committee on Cancer Breast Cancer Staging System.
- Published in:
- Breast Journal, 2006, v. 12, n. 4, p. 294, doi. 10.1111/j.1075-122X.2006.00267.x
- By:
- Publication type:
- Article
Ascertaining Prognosis for Breast Cancer in Node-Negative Patients with Innovative Survival Analysis.
- Published in:
- Breast Journal, 2006, v. 12, n. 1, p. 37, doi. 10.1111/j.1075-122X.2006.00183.x
- By:
- Publication type:
- Article
Letters.
- Published in:
- 2001
- By:
- Publication type:
- Letter
Adjuvant Endocrine Therapy for Breast Cancer: Longer Therapy and the Need for Personalized Treatment--Should We Treat Beyond the Data?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 12, p. 1230
- By:
- Publication type:
- Article
Adjuvant Endocrine Therapy for Breast Cancer: A Commentary.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 6, p. 568
- By:
- Publication type:
- Article
Adjuvant Hormonal Therapy for Premenopausal Breast Cancer: Incorporating Clinical Experience.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 4, p. 332
- By:
- Publication type:
- Article
Ovarian Suppression/Ablation in Premenopausal ER-Positive Breast Cancer Patients Issues and Recommendations.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 1, p. 27
- By:
- Publication type:
- Article
The McTiernan Article Reviewed.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 7, p. 881
- By:
- Publication type:
- Article
Validated or Not Validated? That Is the Question.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 654, doi. 10.1093/jnci/djt026
- By:
- Publication type:
- Article
Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial.
- Published in:
- 2012
- By:
- Publication type:
- Letter to the Editor
Response.
- Published in:
- 2012
- By:
- Publication type:
- Letter
CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 6, p. 427, doi. 10.1093/jnci/djs139
- By:
- Publication type:
- Article
Response: Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Should Observational Studies Be a Thing of the Past?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 7, p. 451, doi. 10.1093/jnci/djn074
- By:
- Publication type:
- Article
Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 17, p. 1262, doi. 10.1093/jnci/dji250
- By:
- Publication type:
- Article
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0568-1
- By:
- Publication type:
- Article
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3600
- By:
- Publication type:
- Article
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 6, p. 703, doi. 10.1007/s12282-019-00973-4
- By:
- Publication type:
- Article
Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference.
- Published in:
- Cancer (0008543X), 2008, v. 112, p. 673, doi. 10.1002/cncr.23194
- By:
- Publication type:
- Article
Combining endocrine agents with chemotherapy: Which patients and what sequence?
- Published in:
- Cancer (0008543X), 2008, v. 112, p. 718, doi. 10.1002/cncr.23189
- By:
- Publication type:
- Article
Combining endocrine agents with chemotherapy: which patients and what sequence?
- Published in:
- 2008
- By:
- Publication type:
- journal article
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
- Published in:
- 2008
- By:
- Publication type:
- research
Do Adjuvant Aromatase Inhibitors Increase the Cardiovascular Risk in Postmenopausal Women With Early Breast Cancer?
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 2, p. 260, doi. 10.1002/cncr.23171
- By:
- Publication type:
- Article
A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Current and future directions in medical therapy for breast carcinoma.
- Published in:
- Cancer (0008543X), 2000, v. 88, n. S12, p. 3065, doi. 10.1002/1097-0142(20000615)88:12+<3065::AID-CNCR25>3.0.CO;2-P
- By:
- Publication type:
- Article
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article